InformAI Company Research Report

Company Overview

Name: InformAI

Mission: Our goal is to lead the transformation of healthcare through AI integration, establishing new standards for patient care and clinical excellence.

Founded: No information is available

Founders: No information is available

Key People:

Jim Havelka (CEO)

Jeff Hopkins (Strategic Advisor)

Mark Kaye (Strategic Advisor)

Headquarters: Houston, Texas

Number of Employees: No information is available

Revenue: No information is available

Known For: InformAI is known for developing AI-driven enterprise software solutions that address specific clinical needs in radiology, radiation oncology, and high acuity informatics. Their goal is to enhance healthcare quality, safety, and efficiency through AI technology.

Products

RadOncAI

Description: RadOncAI enables AI-driven radiation therapy, generating an optimized radiation plan that targets tumors while minimizing exposure to adjacent healthy tissues.

Key Features:

Precise and Efficient: Significantly shortens clinical planning time with AI-optimized plans.

Universal Expertise: Brings high-level planning capabilities to all care settings.

Proven in Practice: Successfully delivered over 700 radiation treatment plans to date.

Safety: Lower off-target radiation reduces complications.

Funding: Funded by Cancer Prevention Research Initiative of Texas (CPRIT).

TransplantAI

Description: TransplantAI is a donor-recipient informatics platform that enables granular AI-powered transplant decisions at the point of care.

Key Features:

In-depth Analysis: Offers predictive insights for matching and outcomes.

Real-time Data Integration: Merges donor and recipient data for streamlined comprehensive assessment.

Proven Effectiveness: Accurate outcome predictions demonstrated in pilots.

Safety: Improved transplant matching and patient outcomes.

Funding: Funded by the National Institutes of Health (NIH) and National Science Foundation (NSF).

SinusAI

Description: SinusAI advances CT imaging diagnostics with AI-enabled precision and efficiency.

Key Features:

Accurate Diagnosis: Achieves clinician-level accuracy.

Streamlined Workflows: Enhances ENT and radiology efficiency with faster detection.

Supporting ENTs & Radiologists: Assisting 11 million annual ENT office visits (US) and 700,000 sinus surgeries.

Safety: Patient retention through treatment.

Recognition: Aunt Minnie Best of Radiology Finalist.

Recent Developments

New Products and Features

Jeff Hopkins Joins InformAI as Strategic Advisor

Date: April 3, 2024

Role: Strategic advisor for the SinusAI product.

Background: Former Worldwide President of Acclarent, Johnson & Johnson’s global ENT medical device business.

Mark Kaye Joins InformAI As Strategic Advisor

Date: March 20, 2024

Role: Strategic advisor for RadOncAI product.

Background: Former Area Vice President for Software and Strategic Initiatives at ViewRay Technologies.

Grants and Funding

Houston health tech company scores $2.2M grant

Date: March 6, 2024

Grant Provider: National Institute of Health (NIH)

Purpose: To support the product development and commercialization of TransplantAI.

NIH Grant for TransplantAI

Date: February 13, 2024

Purpose: Secured grant to advance TransplantAI in solid organ transplantation.

Partnerships

Partnerships:

InformAI works with renowned healthcare organizations, national physician groups, and leading medical imaging companies to build fit-to-purpose AI solutions.